Human leucine-rich A-2-glycoprotein-1 and aminopeptidase N as risk indicators for cancer |
|
---|---|
Short Description |
A diagnostic test which may be used to determine whether an individual or test subject is at risk of developing or having cancer. |
Abstract |
The present diagnostic tests, which involves assessing levels of LRG1, CD13, or the combination thereof in a urine or serum sample from a test subject, may provide additive predictive value beyond that seen with clinical and diagnostic risk factors currently employed by physicians. |
Inventor(s) |
Dr. Aimin Zhou, Ph.D. Professor, Department of Chemistry. |
Commercial Applications |
|
Advantages |
|
IP Information |
Pending U.S. Application |
Related IP |
|
Status |
Available |